Recursion Pharmaceuticals
RXRX
#5297
Rank
A$2.30 B
Marketcap
A$3.70
Share price
-9.93%
Change (1 day)
-42.67%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2026 (TTM): A-$1.31

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$1.36. In 2025 the company made an earnings per share (EPS) of A-$2.24 an increase over its 2024 EPS that were of A-$2.51.

EPS history for Recursion Pharmaceuticals from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.31-41.42%
2025A-$2.24-10.84%
2024A-$2.515.73%
2023A-$2.3714.6%
2022A-$2.0717.39%
2021A-$1.76